AU Patent

AU2016374416A1 — Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug

Assigned to Shionogi and Co Ltd · Expires 2018-06-14 · 8y expired

What this patent protects

A) Formula (I) A medicine that is useful for treating or preventing influenza, etc., said medicine being characterized by comprising a combination of: (A) a compound represented by formula (I), a pharmaceutically acceptable salt thereof, or a solvate of the same [in formula (I): …

USPTO Abstract

A) Formula (I) A medicine that is useful for treating or preventing influenza, etc., said medicine being characterized by comprising a combination of: (A) a compound represented by formula (I), a pharmaceutically acceptable salt thereof, or a solvate of the same [in formula (I): P represents a hydrogen atom or a prodrug-forming group; A

Drugs covered by this patent

Patent Metadata

Patent number
AU2016374416A1
Jurisdiction
AU
Classification
—
Expires
2018-06-14
Drug substance claim
No
Drug product claim
No
Assignee
Shionogi and Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.